Odiparcil For The Prevention Of Venous Thromboembolism

Clinical trial NCT00244725 · COMPLETED

Trial details

NCT number: NCT00244725
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Deep Vein Thrombosis Fibrillation, Atrial Venous Thromboembolism Pulmonary Embolism

Start date: 2005-09-01
Primary completion: 2006-09-01
Enrollment: 961

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.